{"result": "(\"entity\"<|>AMERICAN THYROID ASSOCIATION<|>ORGANIZATION<|>The American Thyroid Association is a professional organization that provides guidelines for the management of thyroid nodules and differentiated thyroid cancer.)\n##\n(\"entity\"<|>ASSOCIAZIONE MEDICI ENDOCRINOLOGI<|>ORGANIZATION<|>The Associazione Medici Endocrinologi is an organization that offers medical guidelines for the diagnosis and management of thyroid nodules.)\n##\n(\"entity\"<|>EUROPEAN THYROID ASSOCIATION<|>ORGANIZATION<|>The European Thyroid Association is an organization that provides guidelines for ultrasound malignancy risk stratification of thyroid nodules in adults.)\n##\n(\"entity\"<|>Haugen BR<|>PERSON<|>Haugen BR is one of the authors of the American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer.)\n##\n(\"entity\"<|>Gharib H<|>PERSON<|>Gharib H is one of the authors of the American Association of Clinical Endocrinologists guidelines for the management of thyroid nodules.)\n##\n(\"entity\"<|>KWAK JY<|>PERSON<|>Kwak JY is one of the authors of the Thyroid Imaging Reporting and Data System for ultrasound features of nodules.)\n##\n(\"entity\"<|>RUSS G<|>PERSON<|>Russ G is one of the authors of the Thyroid Imaging Reporting and Data System and the European Thyroid Association Guidelines for ultrasound malignancy risk stratification.)\n##\n(\"entity\"<|>TIROIDES<|>EVENT<|>The event refers to the classification and management of thyroid nodules and cancers as discussed in the guidelines and studies.)\n##\n(\"relationship\"<|>Haugen BR<|>AMERICAN THYROID ASSOCIATION<|>Haugen BR contributed to the guidelines published by the American Thyroid Association regarding thyroid nodules and cancer management.<|>8)\n##\n(\"relationship\"<|>Gharib H<|>ASSOCIAZIONE MEDICI ENDOCRINOLOGI<|>Gharib H contributed to the medical guidelines for the diagnosis and management of thyroid nodules by the Associazione Medici Endocrinologi.<|>8)\n##\n(\"relationship\"<|>Kwak JY<|>EUROPEAN THYROID ASSOCIATION<|>Kwak JY contributed to the guidelines provided by the European Thyroid Association regarding ultrasound features of thyroid nodules.<|>8)\n##\n(\"relationship\"<|>Russ G<|>EUROPEAN THYROID ASSOCIATION<|>Russ G contributed to the European Thyroid Association guidelines for ultrasound malignancy risk stratification of thyroid nodules.<|>8)\n##\n(\"relationship\"<|>TIROIDES<|>AMERICAN THYROID ASSOCIATION<|>The American Thyroid Association's guidelines address the management of thyroid nodules and cancers, which is the focus of the TIROIDES event.<|>7)\n##\n(\"relationship\"<|>TIROIDES<|>ASSOCIAZIONE MEDICI ENDOCRINOLOGI<|>The Associazione Medici Endocrinologi's guidelines relate to the management of thyroid nodules, which is a key aspect of the TIROIDES event.<|>7)\n##\n(\"relationship\"<|>TIROIDES<|>EUROPEAN THYROID ASSOCIATION<|>The European Thyroid Association's guidelines on ultrasound malignancy risk stratification are relevant to the discussions in the TIROIDES event.<|>7)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: AACE recomiendan realizar PAAF en caso de nódulos entre                                                           Sospecha            Nódulo hipoecoico con uno o más de los siguientes:\n         0,5 y 1 cm, en caso de lesiones subcapsulares o paratraqueales, sospecha de extensión                                                         alta                márgenes irregulares, microcalcificaciones, más alto que                              >70-90\n                                                                                                                                                                           ancho, evidencia de extensión extratiroidea\n         extratiroidea o si hubiera unos antecedentes personales o familiares de cáncer tiroideo o                                                                         Nódulo hipoecoico con márgenes lisos sin\n         de radiación cervical previa. Por lo tanto, no es cierto que nunca se deba realizar PAAF en                                                   Sospecha            microcalcificaciones, extensión extratiroidea, ni morfología                           10-20\n         nódulos menores de 1 cm (opción C falsa).                                                                                                     intermedia          más alta que ancha\n         Finalmente, la realización de PAAF en nódulos puramente quísticos no está indicada, aun-                                                      Sospecha            Nódulo iso- o hiperecoico sin microcalcificaciones, extensión                           5-10\n         que se puede considerar el drenaje del líquido quístico por motivos estéticos o molestias                                                     baja                extratiroidea, ni morfología más alta que ancha\n         locales. Por consiguiente, se puede aceptar como verdadera la opción D.                                                                       Sospecha            Nódulos espongiformes o parcialmente quísticos sin ninguna\n                                                                                                                                                       muy baja            de las características ecográficas descritas en los patrones                             <3\n         Referencias:                                                                                                                                                      de sospecha ecográfica anteriores\n         •  Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management                Benigno             Nódulos puramente quísticos                                                              <1\n            Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines\n            Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26:1-133.                                                Referencias:\n         •  Gharib H, Papini E, Garber JR, Duick DS, Harrell RM, Hegedus L, et al. American Association of Clinical Endocrinologists, American      • Campanella P, Ianni F, Rota CA, Corsello SM, Pontecorvi A. Quantification of cancer risk of each clinical and ultrasonographic\n            College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and            suspicious feature of thyroid nodules: a systematic review and meta-analysis. Eur J Endocrinol. 2014;170:R203-11.\n            Management of Thyroid Nodules--2016 Update. Endocr Pract. 2016;22:622-39.                                                               • Kwak JY, Han KH, Yoon JH, Moon HJ, Son EJ, Park SH, et al. Thyroid Imaging Reporting and Data System for US features of nodules:\n                                                                                                                                                      a step in establishing better stratification of cancer risk. Radiology. 2011;260:892-9.\n                                                                                                                                                    • Russ G, Bigorgne C, Royer B, Rouxel A, Bienvenu-Perrard M. The Thyroid Imaging Reporting and Data System (TIRADS) for ultrasound\n                                                                                                                                                      of the thyroid. J Radiol. 2011;92:701-13.\n                                                                                                                                                    • Russ G, Bonnema SJ, Erdogan MF, Durante C, Ngu R, Leenhardt L. European Thyroid Association Guidelines for Ultrasound\n                                                                                                                                                      Malignancy Risk Stratification of Thyroid Nodules in Adults: The EU-TIRADS. Eur Thyroid J. 2017;6:225-37.\n\n\n\n172                                                                                                                                                                                                                                                                                  173\n---\n                                                                                                                                                                                                                                                 TIROIDES                          3\n\n\n\n        36     ¿Cuál es el riesgo de malignidad más aproximado en nódulos tiroideos                                                                   COMENTARIO\n               descubiertos incidentalmente por captación en una PET con                                                                              En 2017, la OMS publicó una nueva clasificación de tumores tiroideos que introduce una\n               18F-fluorodesoxiglucosa (18F-FDG)?                                                                                                     serie de modificaciones respecto a la clasificación anterior de 2004.\n               A. 10%.                                                                                                                                Uno de los cambios introducidos es                   la definición de tumor folicular de potencial maligno\n               B. 33%.                                                                                                                                incierto como “aquellos tumores encapsulados o bien delimitados con células foliculares\n               C. 55%.                                                                                                                                bien diferenciadas sin núcleos de carcinoma papilar y cuestionable invasión capsular o\n               D.   80%.                                                                                                                              vascular” (opción A cierta).\n                                                                                                                                                      Igualmente, debido a sus peculiares características clinicopatológicas y moleculares, los\n                                                                                                                                                      tumores      de células de Hürthle (oncocíticos) se consideran                       un grupo aparte en la nueva\n               COMENTARIO                                                                                                                             clasificación de la OMS (opc\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}